ライフサイエンスコーパス: transesophageal echocardiography

1 contrast opacification, and when indicated, transesophageal echocardiography.

2 others, can all be reliably performed using transesophageal echocardiography.

3 further paved the way to the application of transesophageal echocardiography.

4 myocardial biopsies were performed guided by transesophageal echocardiography.

5 lic areas of the left ventricle by utilizing transesophageal echocardiography.

6 al biopsies (2 per patient) were obtained by transesophageal echocardiography.

7 line), and mitral competence was assessed by transesophageal echocardiography.

8 , 4D flow metrics were compared with Doppler transesophageal echocardiography.

9 pulation, were examined by transthoracic and transesophageal echocardiography.

10 dysfunction during bypass surgery, guided by transesophageal echocardiography.

11 LA pressure measurements and intraoperative transesophageal echocardiography.

12 potential cardioembolic source detected with transesophageal echocardiography.

13 ith a right-to-left shunt was confirmed with transesophageal echocardiography.

14 motion and stroke volume were monitored via transesophageal echocardiography.

15 ypertrophic cardiomyopathy by intraoperative transesophageal echocardiography.

16 phageal echocardiography, and specificity of transesophageal echocardiography.

17 graphy, was not cost-effective compared with transesophageal echocardiography.

18 ortening for the measured wall stress, using transesophageal echocardiography.

19 at account for the mobile components seen on transesophageal echocardiography.

20 disease of the thoracic aorta as defined by transesophageal echocardiography.

21 nd geometry of the regurgitant jets by using transesophageal echocardiography.

22 te to severe TR underwent 3-dimensional (3D) transesophageal echocardiography.

23 egree of TA enlargement as assessed using 3D transesophageal echocardiography.

24 han IVC and PP, but its measurement requires transesophageal echocardiography.

25 nts at the 6-month follow-up as evaluated by transesophageal echocardiography.

26 greatest with type II or III microbubbles on transesophageal echocardiography.

27 ight ventricular function was assessed using transesophageal echocardiography.

28 40) and similar in patients with and without transesophageal echocardiography.

29 e thickness and morphology were evaluated by transesophageal echocardiography.

30 lvular dimensions by real-time 3-dimensional-transesophageal-echocardiography.

31 erwent MDCT in addition to transthoracic and transesophageal echocardiography 1 to 3 months post-TAVR

32 dentifying the risk for EEs compared with 2D transesophageal echocardiography (2DTEE).

33 4C view was smaller than when measured by 3D-transesophageal echocardiography (3.90+/-0.63 versus 4.3

34 o assess RVOT morphology using 3-dimensional transesophageal echocardiography (3D TEE).

35 o had undergone cardiac CT and 3-dimensional transesophageal echocardiography (3D-TEE) were retrospec

36 completed Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) clinical trial.

37 The Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) multicenter stu

38 The Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) trial found no

39 In 16 patients, transesophageal echocardiography after 30 days confirmed

40 relatively higher in patients evaluated with transesophageal echocardiography after a cerebral ischem

41 Transesophageal echocardiography allows a detailed evalu

42 ly significant aortic atherosclerosis (using transesophageal echocardiography and aortic ultrasound)

43 e, that can be detected by transthoracic and transesophageal echocardiography and by cardiac magnetic

44 , the valve function remained unchanged, and transesophageal echocardiography and computed tomography

45 e use of ultrasonographic techniques such as transesophageal echocardiography and contrast transcrani

46 Follow-up consisted of sequential transesophageal echocardiography and fluoroscopy as well

47 The device was placed with the help of transesophageal echocardiography and fluoroscopy.

48 ortic atheromas (as seen with intraoperative transesophageal echocardiography and intraoperative epia

49 Transesophageal echocardiography and magnetic resonance

50 n 85% of patients as documented by follow-up transesophageal echocardiography and MDCT.

51 Patients underwent transthoracic and transesophageal echocardiography and multidetector compu

52 matched healthy volunteers underwent initial transesophageal echocardiography and rheumatologic evalu

53 We performed transesophageal echocardiography and rheumatologic evalu

54 araminol and confirmation by bubble-contrast transesophageal echocardiography and right heart cathete

55 technology, including live three-dimensional transesophageal echocardiography and single-beat three-d

56 Although transesophageal echocardiography and Surviving Sepsis Ca

57 Agreement for treatment decision between transesophageal echocardiography and Surviving Sepsis Ca

58 Accordingly, the agreement was weak between transesophageal echocardiography and Surviving Sepsis Ca

59 MV annular geometry with 3-dimensional (3D) transesophageal echocardiography and the association of

60 ging techniques that facilitate BMV, such as transesophageal echocardiography and the recently develo

61 k factors, aortic atherosclerosis (imaged by transesophageal echocardiography) and aortic valve abnor

62 deployment and <5 mm leak by post-procedure transesophageal echocardiography), and no major complica

63 c balloon, counter pulsation, and the use of transesophageal echocardiography, and improved intra-ope

64 ent of 2 sonomicrometers on the left atrium, transesophageal echocardiography, and invasive hemodynam

65 rease of RV free wall thickness, measured by transesophageal echocardiography, and of RV weight/body

66 ombus, quality of life after stroke, cost of transesophageal echocardiography, and specificity of tra

67 Direct measurement of atrial velocity by transesophageal echocardiography appears to be useful fo

68 Biplane and multiplane transesophageal echocardiography are highly accurate for

69 tomography, magnetic resonance imaging, and transesophageal echocardiography are reliable tools for

70 scanners in trauma centers limits the use of transesophageal echocardiography as a first-line diagnos

71 Transesophageal echocardiography assessed the degree of

72 A second transesophageal echocardiography assessment (T2) was per

73 Inotropes were prescribed based on transesophageal echocardiography assessment in 14 patien

74 ing and inotropic support derived from early transesophageal echocardiography assessment of hemodynam

75 Transesophageal echocardiographies at baseline, one, and

76 We performed intraoperative transesophageal echocardiography at the insertion and ex

77 ifice area (53%) measured with 3-dimensional transesophageal echocardiography, at 6.05 cm(2) and 0.63

78 tforms of transthoracic echocardiography and transesophageal echocardiography, because hardware and s

79 esults were correlated with transthoracic or transesophageal echocardiography, blood cultures, and th

80 patients with S. aureus bacteremia for whom transesophageal echocardiography can be safely avoided h

81 Transesophageal echocardiography can further delineate t

82 Transesophageal echocardiography can have many helpful u

83 Transesophageal echocardiography can identify low-risk g

84 Transesophageal echocardiography can safely be performed

85 d on primary key words: 3D echocardiography, transesophageal echocardiography, cardiac surgery, and/o

86 The modern imaging techniques of transesophageal echocardiography, CT, and MRI are report

87 plantation, comprehensive 3-dimensional (3D) transesophageal echocardiography data were acquired for

88 Transesophageal echocardiography demonstrated all closur

89 Transesophageal echocardiography detected incomplete LAA

90 Although transesophageal echocardiography diagnosis of aortic tra

91 of subjects with ASA and cerebral ischemia, transesophageal echocardiography did not detect an alter

92 m, which makes diagnosis by transthoracic or transesophageal echocardiography difficult.

93 ient had anemia and only three patients with transesophageal echocardiography documented left ventric

94 Significant advances in transesophageal echocardiography, electron beam computed

95 Three-dimensional transesophageal echocardiography enables assessment of a

96 he Edwards SAPIEN and had intraprocedural 3D transesophageal echocardiography evaluation of the mitra

97 in studies using invalid controls, unblinded transesophageal echocardiography examinations, and data

98 We examined whether high-risk transesophageal echocardiography features are seen more

99 Transesophageal echocardiography features such as PFO si

100 The association of these transesophageal echocardiography features with other mar

101 n Cryptogenic Stroke Study (PICSS) evaluated transesophageal echocardiography findings in patients en

102 iography findings did not predict subsequent transesophageal echocardiography findings of endocarditi

103 Transesophageal echocardiography follow-up revealed that

104 Among 63 patients with acute closure and transesophageal echocardiography follow-up, there were 3

105 The accuracy of transesophageal echocardiography for ancillary findings

106 The accuracy of transesophageal echocardiography for diagnosis of acute

107 iagnostic accuracy of biplane and multiplane transesophageal echocardiography for dissection and intr

108 The overall sensitivity and specificity of transesophageal echocardiography for the presence of dis

109 ned transmural myocardial biopsies guided by transesophageal echocardiography from patients with isch

110 rhagic events was significantly lower in the transesophageal-echocardiography group (18 events [2.9 p

111 ive embolic events among 619 patients in the transesophageal-echocardiography group [0.8 percent]) vs

112 Patients in the transesophageal-echocardiography group also had a shorte

113 Transesophageal echocardiography guidance decreased from

114 olytic therapy sessions were performed under transesophageal echocardiography guidance.

115 parable to those on warfarin with or without transesophageal echocardiography guidance.

116 Transesophageal echocardiography-guided beating-heart MV

117 aortic annular sizing using a traditional 2D transesophageal echocardiography-guided or a novel CT-gu

118 month period, 191 of 264 patients undergoing transesophageal echocardiography had adequate visualizat

119 Transesophageal echocardiography has also become more us

120 Transesophageal echocardiography has been increasingly p

121 Recently, transesophageal echocardiography has been shown to be a

122 ring the last 6 years, the increasing use of transesophageal echocardiography has shown that atherosc

123 and found to have mobile aortic atheroma on transesophageal echocardiography have a high incidence o

124 Recently, computed tomography and transesophageal echocardiography have been used for seri

125 rative management as follows: intraoperative transesophageal echocardiography; hypothermic circulator

126 Transesophageal echocardiography identified well-organiz

127 Procedural transesophageal echocardiography imaging was reviewed fo

128 9) or atrial fibrillation (n = 44) underwent transesophageal echocardiography immediately before and

129 in question since the advent of ultrasound (transesophageal echocardiography), improvements in magne

130 47 patients, LAA thrombus was identified on transesophageal echocardiography in 10 (21%) patients (O

131 TAD was also measured using 3D-transesophageal echocardiography in 183 patients (long a

132 We performed transesophageal echocardiography in 255 patients with fi

133 ed, and ventricular function was assessed by transesophageal echocardiography in 26 donors before hea

134 ons of the thoracic aorta were measured with transesophageal echocardiography in 373 subjects partici

135 We performed transesophageal echocardiography in 43 patients and acqu

136 We performed transesophageal echocardiography in 47 consecutive, nona

137 The value of precordial or transesophageal echocardiography in addition to clinical

138 s cost $9000 per quality-adjusted life-year; transesophageal echocardiography in all patients cost $1

139 Physicians should consider doing transesophageal echocardiography in all patients with ne

140 o review the perioperative use of noncardiac transesophageal echocardiography in anesthesiology and t

141 Anesthesiologists are increasingly using transesophageal echocardiography in both cardiac and non

142 To demonstrate the applicability of transesophageal echocardiography in clinical practice, t

143 Routine use of intraoperative transesophageal echocardiography in major thoracic surge

144 New research on the use of transesophageal echocardiography in patients with stroke

145 iagnostic accuracy of biplane and multiplane transesophageal echocardiography in patients with suspec

146 d to identify studies addressing the role of transesophageal echocardiography in S. aureus bacteremia

147 k on the use of computed tomography (CT) and transesophageal echocardiography in screening for and fa

148 355 age- and sex-matched patients undergoing transesophageal echocardiography in search of a cardiac

149 alue of CMR as compared to transthoracic and transesophageal echocardiography in the diagnostic evalu

150 The role of transesophageal echocardiography in the evaluation of AS

151 ients, LAA emptying velocity was measured by transesophageal echocardiography in the setting of pharm

152 Such invasive imaging tools include transesophageal echocardiography, intracardiac echocardi

153 ntrast detected within the thoracic aorta by transesophageal echocardiography is a common and importa

154 Transesophageal echocardiography is a safe procedure tha

155 Transesophageal echocardiography is a useful technique f

156 disease of the thoracic aorta as defined by transesophageal echocardiography is associated with a hi

157 The sensitivity of transesophageal echocardiography is high, but the diagno

158 ng right-to-left shunts in settings in which transesophageal echocardiography is not desirable.

159 Transesophageal echocardiography is recognized as more s

160 Measurement of pericardial thickness with transesophageal echocardiography is reproducible and sho

161 Transesophageal echocardiography is the modality of choi

162 acquire full-volume real-time 3-dimensional transesophageal echocardiography loops in 11 normal subj

163 undergoing cardiac surgery, we recorded with transesophageal echocardiography mitral valve early (E)

164 Real-time 3-dimensional transesophageal echocardiography of the mitral valve was

165 Real-time 3-dimensional transesophageal echocardiography of the mitral valve was

166 rior vena cava diameter (SVC) measured using transesophageal echocardiography, of inferior vena cava

167 Full-volume real-time 3-dimensional transesophageal echocardiography offers a unique opportu

168 iography in clinical practice, the effect of transesophageal echocardiography on the cardiac surgical

169 o either treatment guided by the findings on transesophageal echocardiography or conventional treatme

170 ort function by either direct visualization, transesophageal echocardiography, or atrioventricular ve

171 s problem, some trauma centers have used CT, transesophageal echocardiography, or both, in their diag

172 as the only indication for anticoagulation, transesophageal echocardiography performed only in patie

173 presenting with neurologic events, in which transesophageal echocardiography plays an important role

174 institution routinely had an intraoperative transesophageal echocardiography, prospectively quantifi

175 terization are feasible and, guided by fetal transesophageal echocardiography, provide potential alte

176 Transesophageal echocardiography provides a highly accur

177 Transesophageal echocardiography provides complementary

178 Transthoracic and transesophageal echocardiography provides complementary

179 Real-time 3-dimensional transesophageal echocardiography provides insights into

180 Thus, real-time 3-dimensional transesophageal echocardiography provides new insights t

181 ze and function of the ventricles as seen on transesophageal echocardiography, renal function and sur

182 It has been proposed that if transesophageal echocardiography reveals no atrial throm

183 We found no evidence that the proposed transesophageal echocardiography risk markers of large P

184 d the feasibility of real-time 3-dimensional transesophageal echocardiography (RT3DTEE) in determinin

185 st few decades, the effect of intraoperative transesophageal echocardiography's (TEE) influence on pe

186 s, including transthoracic echocardiography, transesophageal echocardiography, sequential approaches,

187 The superior resolution achieved with transesophageal echocardiography should allow better per

188 Transesophageal echocardiography should be considered in

189 ass when aortic arch atheromas are seen with transesophageal echocardiography (six times the general

190 d MR, whereupon biplane videofluoroscopy and transesophageal echocardiography studies were repeated.

191 The present 3-dimensional (3D) transesophageal echocardiography study aimed to elucidat

192 ntricular systolic dysfunction, unremarkable transesophageal echocardiography study consistent with s

193 rade graft perfusion, and the uniform use of transesophageal echocardiography substantially decrease

194 75 to 0.84] vs. 85% [95% CI: 0.81 to 0.89]), transesophageal echocardiography (TEE) (89% [95% CI: 0.8

195 We studied 19 patients undergoing BMV using transesophageal echocardiography (TEE) (Chicago, Illinoi

196 o model and quantify the aortic root from 3D transesophageal echocardiography (TEE) and computed tomo

197 LAA closure was confirmed with transesophageal echocardiography (TEE) and contrast fluo

198 This study sought to determine the role of transesophageal echocardiography (TEE) and epiaortic ult

199 The goal of this study was to compare transesophageal echocardiography (TEE) and intracardiac

200 nclude transthoracic echocardiography (TTE), transesophageal echocardiography (TEE) and transcranial

201 Cardiac catheterization and transesophageal echocardiography (TEE) are currently use

202 of aortic stenosis include transthoracic and transesophageal echocardiography (TEE) as well as transv

203 ght (28%) of 136 patients had intraoperative transesophageal echocardiography (TEE) before CABG, and

204 Screening for atrial thrombi with transesophageal echocardiography (TEE) before cardiovers

205 Subsequent studies suggest that 3D transesophageal echocardiography (TEE) can also accurate

206 whether quantitation of thrombus burden with transesophageal echocardiography (TEE) can help risk-str

207 We hypothesize that pre-MVRep transesophageal echocardiography (TEE) can predict postr

208 We analyzed clinical, transthoracic and transesophageal echocardiography (TEE) data in 23 patien

209 spite a normal transthoracic echocardiogram, transesophageal echocardiography (TEE) detected a large

210 atrial spontaneous echo contrast (LASEC) by transesophageal echocardiography (TEE) has been proposed

211 Valve excrescences detected by transesophageal echocardiography (TEE) have been conside

212 ler transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) have reduced hemo

213 Performing transesophageal echocardiography (TEE) in all patients w

214 Hemodynamic monitoring using transesophageal echocardiography (TEE) in patients with

215 me (RT) 3-dimensional (3D) transthoracic and transesophageal echocardiography (TEE) in the evaluation

216 Transesophageal echocardiography (TEE) is an integral pa

217 The use of two-dimensional (2D) transesophageal echocardiography (TEE) is nearly univers

218 Transesophageal echocardiography (TEE) is the diagnostic

219 Transesophageal echocardiography (TEE) is the gold stand

220 Transesophageal echocardiography (TEE) should be ideally

221 t" jet could be identified on the postbypass transesophageal echocardiography (TEE) study in only 1 p

222 The purpose of this study was to use transesophageal echocardiography (TEE) to define the mec

223 This study used 3D transesophageal echocardiography (TEE) to determine the

224 We developed a method of transesophageal echocardiography (TEE) to evaluate murin

225 pared cross-sectional three-dimensional (3D) transesophageal echocardiography (TEE) to two-dimensiona

226 Transesophageal echocardiography (TEE) was performed in

227 Pulsed-wave Doppler transesophageal echocardiography (TEE) was performed wit

228 Biplane videofluoroscopy and transesophageal echocardiography (TEE) were performed (o

229 clinical probability of the disease and (2) transesophageal echocardiography (TEE) would be most use

230 TTE contrast study and the gold standard, of transesophageal echocardiography (TEE), and assessed its

231 These lesions can be observed easily with transesophageal echocardiography (TEE), but the accuracy

232 ardiography, particularly the development of transesophageal echocardiography (TEE), have revolutioni

233 f uncorrected MR, measured by intraoperative transesophageal echocardiography (TEE), in CABG patients

234 Echocardiography, particularly transesophageal echocardiography (TEE), is a vital diagn

235 tify patients with LA thrombus, diagnosed by transesophageal echocardiography (TEE), who were in SR d

236 A transesophageal echocardiography (TEE)-guided strategy h

237 study was to compare the relative cost of a transesophageal echocardiography (TEE)-guided strategy v

238 enter study was a prospective trial in which transesophageal echocardiography (TEE)-guided treatment

239 re is most successful by assessing them with transesophageal echocardiography (TEE).

240 ood pressure, electrocardiography (EKG), and transesophageal echocardiography (TEE).

241 ent between ICE and simultaneously performed transesophageal echocardiography (TEE).

242 rgitation (PPR) identified by intraoperative transesophageal echocardiography (TEE).

243 valuated the accuracy of VC imaging of AR by transesophageal echocardiography (TEE).

244 descending thoracic aorta in comparison with transesophageal echocardiography (TEE).

245 0 patients with aortic plaques identified by transesophageal echocardiography (TEE).

246 ft ventricular systolic function by means of transesophageal echocardiography (TEE).

247 connection can be made with confidence using transesophageal echocardiography (TEE).

248 age 67 years, range 29 to 86) who underwent transesophageal echocardiography (TEE).

249 itially positioned by use of fluoroscopy and transesophageal echocardiography (TEE).

250 and mobile "aortic debris" imaged in vivo by transesophageal echocardiography (TEE).

251 ebral ischemia undergoing investigation with transesophageal echocardiography (TEE).

252 tion (AF) ablation, attributed to the use of transesophageal echocardiography (TEE).

253 nsmural myocardial biopsies (n=37) guided by transesophageal echocardiography to determine the extent

254 re and after tightening of each STRING using transesophageal echocardiography to grade IMR.

255 The use of transesophageal echocardiography to guide the management

256 nter who had undergone biplane or multiplane transesophageal echocardiography to identify aortic diss

257 The use of transesophageal echocardiography to identify PFO was per

258 -matched control subjects underwent protocol transesophageal echocardiography to image the mitral val

259 etal cardiac catheterization guided by fetal transesophageal echocardiography to provide alternative

260 ce was inserted into the heart and guided by transesophageal echocardiography to the ventricular surf

261 A 5.5/7.5-MHz biplanar transesophageal echocardiography transducer was advanced

262 tial implantation, as identified by means of transesophageal echocardiography, underwent additional b

263 Transesophageal echocardiography velocities modestly but

264 Transesophageal echocardiography was 86% to 100% sensiti

265 Closure rate as judged by transesophageal echocardiography was 88% initially and 1

266 Pericardial thickness > or = 3 mm on transesophageal echocardiography was 95% sensitive and 8

267 tudies with a total of 4050 patients, use of transesophageal echocardiography was associated with hig

268 ve pericarditis who underwent intraoperative transesophageal echocardiography was compared with peric

269 Precardioversion transesophageal echocardiography was encouraged, particu

270 Transesophageal echocardiography was first performed (T1

271 Transesophageal echocardiography was performed at 45 day

272 For D110, D150, and warfarin, transesophageal echocardiography was performed before 25

273 Transesophageal echocardiography was performed before di

274 Transesophageal echocardiography was performed during fo

275 MV imaging using 3D transesophageal echocardiography was performed in 10 nor

276 Transesophageal echocardiography was performed in 385 su

277 Transesophageal echocardiography was performed in 581 su

278 A transesophageal echocardiography was performed in 74% of

279 Transesophageal echocardiography was used to determined

280 Transesophageal echocardiography was used to evaluate fe

281 Color Doppler transesophageal echocardiography was used to grade MR on

282 echocardiography, alone or in sequence with transesophageal echocardiography, was not cost-effective

283 cal prosthetic valve dysfunction assessed by transesophageal echocardiography were included in this p

284 sure recordings with simultaneous Doppler by transesophageal echocardiography were obtained from 11 p

285 Biplane videofluoroscopy and transesophageal echocardiography were performed before a

286 Biplane videofluoroscopy and transesophageal echocardiography were performed before a

287 To summarize the use of transesophageal echocardiography when investigating hypo

288 urgitation in group 1 based on postoperative transesophageal echocardiography, whereas group 2 had an

289 Because 3-dimensional transesophageal echocardiography with gated rotational a

290 RECOMMENDATION 5: Both transesophageal echocardiography with short-term prior a

291 Monitored by fetal transesophageal echocardiography, with an 8F or 10F, 10-